✦ LIBER ✦

114 Phase II trial of vinorelbine chemotherapy in patients with malignant peritoneal mesothelioma

✍ Scribed by Steele, J.P.C.; Klabatsa, A.; Fennell, D.A.; Bowen, R.L.; Sheaff, M.T.; Reznek, R.A.; Rudd, R.M.

Book ID: 118573800
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 66 KB
Volume: 54
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(07)70190-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of vinorelbine and oxalip

Phase II trial of vinorelbine and oxaliplatin in patients with malignant pleural mesothelioma

✍ Steele, J.P.C; Shamash, J; Evans, M.T; Gower, N.H; Rudd, R.M 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Phase II trial of vinorelbine and oxalip

Phase II trial of vinorelbine and oxaliplatin as first-line therapy in malignant pleural mesothelioma

✍ Fennell, Dean A.; C. Steele, Jeremy P.; Shamash, Jonathan; Sheaff, Michael T.; E 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Phase II trial of carboplatin (JM8) in t

Phase II trial of carboplatin (JM8) in treatment of patients with malignant mesothelioma

✍ Edward K. Mbidde; Stephen J. Harland; A. Hilary Calvert; Ian E. Smith 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 228 KB

Phase II randomized trial comparing vino

Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies

✍ Mario Airoldi; Fulvia Pedani; Giovanni Succo; Anna Maria Gabriele; Riccardo Rago 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 2 views

Results of a phase II trial of combined

Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura

✍ Sébastien Kasseyet; Philippe Astoul; Christian Boutin 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## BACKGROUND. Malignant pleural mesothelioma is associated with a poor prognosis because of its resistance to treatment. The authors conducted a Phase II trial in which two drugs (etoposide and 5-fluorouracil) were added to the Cancer and Leukemia Group B cisplatin-mitomycin regimen in an effort t

Cediranib in patients with malignant mes

Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium

✍ Campbell, Nicholas P.; Kunnavakkam, Rangesh; Leighl, Natasha; Vincent, Mark D.; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 381 KB